All Penny Stocks.com News: Cellceutix Gets Nod from IRB for Additional Enrollment in Clinical Trial of New Cancer Drug Candidate
AllPennyStocks.com Media, Inc. (AllPennyStocks.com/) announces its latest article titled "Cellceutix Gets Nod From IRB For Additional Enrollment in Clinical Trial of New Cancer Drug Candidate."
View full press release